Related by context. All words. (Click for frequent words.) 72 endometrial hyperplasia 72 postmenopausal hormone 71 advanced adenoma 71 colorectal adenoma 71 atypical hyperplasia 70 Heavy menstrual bleeding 69 ASCUS 69 Papillary 69 leiomyomas 69 deep venous thromboses 69 Adenomas 69 endometrial carcinoma 69 GnRH agonists 69 CIN3 69 chlamydial infection 69 serum phosphate 69 invasive ductal 68 lobular breast cancer 68 colorectal neoplasms 68 adenomatous polyps 68 #.#ng/ml 68 lobular cancer 68 node metastases 68 HGPIN 68 progesterone receptor negative 68 specific antigen PSA 68 ductal breast cancer 68 renal cell carcinomas 68 advanced adenomas 68 pCR 67 oesophageal adenocarcinoma 67 HER2 amplification 67 HER2 overexpression 67 nonmelanoma skin cancers 67 invasive lobular 67 advanced neoplasia 67 Leukemias 67 elevated CRP 67 aminotransferases 67 Squamous 67 endometrial cancers 67 atypia 66 lobular carcinoma 66 ductal cancer 66 subclinical hyperthyroidism 66 lymphocytosis 66 breast endometrial 66 elevated LDH 66 CIN2 + 66 testicular tumors 66 thyroid nodules 66 SLNB 66 serous ovarian cancer 66 HER2 expression 66 serum estradiol 66 precursor lesions 66 moderate renal impairment 66 bacteriuria 66 CVD mortality 66 grade cervical intraepithelial 66 endometriosis ovarian cysts 66 serum prostate 66 precancerous cervical 66 hip BMD 66 prostate cancer CaP 66 postmenopausal hormone replacement 66 prostate specific 66 flutamide 66 salpingo oophorectomy 66 serum PSA 65 nonmelanoma skin cancer 65 seminomas 65 serum urate levels 65 gastric cardia 65 breast carcinoma 65 K ras mutations 65 urolithiasis 65 grade squamous intraepithelial 65 serum creatinine levels 65 adenomatous 65 benign noncancerous 65 Asymptomatic 65 HIV HCV coinfected 65 SUVmax 65 thromboembolic disease 65 abdominal adiposity 65 HER2 positive cancers 65 PSA nadir 65 differentiated thyroid 65 mammographic density 65 neoplasias 65 hormone receptor negative 65 rebleeding 65 polyp recurrence 65 recurrent UTI 65 antigen PSA levels 65 lobular carcinomas 65 serum calcium levels 65 malignant neoplasm 65 colorectal adenomas 65 pheochromocytomas 65 thyroid carcinoma 65 NMIBC 65 Inhibin B 65 SGPT 65 invasive aspergillosis 65 fibroids endometriosis 65 glomerular filtration 65 Hypotension 65 estimated glomerular filtration 65 subependymal giant cell 65 ductal carcinomas 65 invasive lobular carcinoma 65 invasive carcinoma 65 PCNSL 65 thyroglobulin 65 BRCA1 mutation carriers 64 eosinophilic pneumonia 64 EXJADE 64 Endometrial cancer 64 ductal lobular 64 thyrotropin levels 64 elevated ALT 64 transferrin saturation 64 thyroid hormone levels 64 Chlamydia infections 64 PSADT 64 skeletal metastases 64 CIN3 + 64 asymptomatic carotid stenosis 64 Refractory Hodgkin Lymphoma 64 Skin sterol 64 adenoma recurrence 64 hamartomas 64 nonalcoholic steatohepatitis 64 thyrotropin 64 recurrent VTE 64 tibolone 64 colorectal polyp 64 neoplasia PIN 64 squamous cell lung cancer 64 albumin excretion 64 HBeAg negative 64 transaminase levels 64 carotid stenosis 64 nonvertebral fractures 64 Metastatic Prostate Cancer 64 HER2 amplified 64 adenoma 64 hepatorenal syndrome 64 elevated serum creatinine 64 hereditary predisposition 64 intestinal polyps 64 precancerous condition 64 B7 H3 64 postoperative mortality 64 ADPKD 64 Adenocarcinoma 64 ALT flares 64 adenocarcinomas 64 Folfox 64 lichen planus 64 peritoneal cancer 64 epithelial ovarian 64 gonococcal infections 64 hepatic enzymes 64 nonvertebral fracture 64 subclinical hypothyroidism 64 polycystic ovary syndrome PCOS 64 abnormal vaginal bleeding 64 Adjuvant chemotherapy 64 malignant polyps 64 chronic prostatitis 64 overt hypothyroidism 64 relapsed MM 64 prednisone prednisolone 64 intravenous bisphosphonates 64 chorioamnionitis 64 Endometrial 64 papillary carcinoma 63 colorectal cancer CRC 63 precancer 63 gallstone disease 63 metastatic malignant 63 ovarian breast 63 IgA deficiency 63 CIN2 63 thyroid stimulating hormone 63 candidemia 63 serum aminotransferase levels 63 Serious adverse reactions 63 Microalbuminuria 63 genital ulcers 63 cTnT 63 bladder ovarian 63 orchiectomy 63 situ LCIS 63 GISTs 63 pulmonary metastases 63 cardiac troponin T 63 elevated LDL cholesterol 63 distal colon cancer 63 BRCA1 mutations 63 metachronous 63 perioperative mortality 63 leukocytosis 63 serum ferritin 63 antiandrogen 63 serum urate 63 squamous cell cancers 63 thyroid dysfunction 63 extrapyramidal symptoms 63 macroalbuminuria 63 atherogenic dyslipidemia 63 Comorbidities 63 cerebral microbleeds 63 fetal malformations 63 HbF 63 colorectal pancreatic 63 BRCA2 mutation carriers 63 Erythropoietic therapies may 63 TEAEs 63 PASI scores 63 Carcinoid tumors 63 precancerous tumors 63 osteosarcomas 63 Chlamydia trachomatis infection 63 neutrophil counts 63 Thromboembolism 63 definite stent thrombosis 63 distal colon 63 Postoperative complications 63 Basal Cell 63 neoplasia 63 alanine aminotransferase 63 N telopeptide 63 prostate abnormalities 63 gastric adenocarcinoma 63 B Cell Lymphoma 63 abnormal Pap smears 63 cervical lesions 63 nodal metastasis 63 external genital lesions 63 lumbar disk herniation 63 recurrent venous thromboembolism 63 aspartate aminotransferase AST 63 prolonged QT interval 63 Metastases 63 CP CPPS 63 hypercalciuria 63 epithelial tumors 63 neurologic complications 63 Recurrences 63 adrenocortical cancer 63 GnRH agonist 63 antiphospholipid antibodies 63 epididymitis 63 Ejection Fraction 63 HBV infections 63 MALT lymphoma 63 allogeneic HSCT 63 orchitis 63 Venous thromboembolism 63 mammographically 63 microvessel density 63 catheter angiography 63 coinfection 63 hepatic cirrhosis 63 glomerular filtration rate 63 microbleeds 63 ano genital warts 63 MGUS 63 fetal chromosomal 63 alanine aminotransferase ALT 63 cervical intraepithelial neoplasia 63 GSTP1 63 BRCA mutations 63 testicular germ cell 63 hormone therapy estrogen 63 ACE Inhibitors 63 aminotransferase ALT 63 basal cell nevus syndrome 63 Invasive Breast Cancer 63 acute aortic dissection 63 lipid elevations 63 gonococcal infection 63 histologic subtype 63 varicoceles 63 Menopausal hormone therapy 63 anal cancers 63 latent celiac disease 63 Malignant Melanoma 63 Prostatitis 63 de ath 63 postoperative morbidity 63 perioperative complications 63 noncardiac 63 CHD mortality 63 Basal cell 62 serum lipid levels 62 colonoscopy sigmoidoscopy 62 antibody titer 62 serum IGF 62 cervical carcinoma 62 diverticular bleeding 62 leukaemias 62 EUS FNA 62 smoldering myeloma 62 benign proliferative breast 62 anticonvulsant medications 62 naturally occurring estrogen 62 microalbuminuria 62 macrovascular events 62 retrograde ejaculation 62 cytoreduction 62 epithelial ovarian cancer 62 PAOD 62 postoperative complication 62 Colon polyps 62 frequently benign tumor 62 BRCA2 carriers 62 endometrial thickness 62 esophageal cancers 62 EBUS FNA 62 mL/min/#.# m 2 62 atrophic gastritis 62 post transplant lymphoproliferative 62 BRCA2 mutations 62 histological subtype 62 thyrotoxicosis 62 Hashimoto thyroiditis 62 paragangliomas 62 aldosterone antagonist 62 untreated celiac disease 62 colorectal neoplasia 62 estrogen progestin therapy 62 hamartoma 62 hyperplastic 62 pancreatic lung 62 CMV infection 62 F FDG PET 62 PSA velocity 62 Renal impairment 62 intact parathyroid hormone 62 prolactin levels 62 androgen deprivation 62 mucinous 62 leucopenia 62 adjuvant radiotherapy 62 carotid artery blockage 62 lipid lowering agents 62 TMP SMX 62 Cholangiocarcinoma 62 serum testosterone 62 urothelial carcinoma 62 urine cytology 62 seropositivity 62 deCODE BreastCancer 62 Polycystic ovary syndrome PCOS 62 gastric corpus 62 papillary renal cell carcinoma 62 complete cytogenetic response 62 urethral stricture 62 colorectal carcinoma 62 hematopoietic cancers 62 platelet reactivity 62 NATRECOR ® 62 salivary flow 62 serum cortisol 62 ischemic lesions 62 testicular cancers 62 hepatic steatosis 62 serum potassium 62 Coronary Artery Bypass Graft 62 bladder cancers 62 binary restenosis 62 troponin T 62 metastatic GIST 62 Mitomycin C 62 SGOT 62 dysglycemia 62 arterial calcification 62 deCODE BreastCancer TM 62 Febrile neutropenia 62 gastric carcinoma 62 vaginal progesterone gel 62 ductal 62 invasive carcinomas 62 adnexal mass 62 cryptogenic 62 molar pregnancy 62 postoperative chemotherapy 62 hydroxyvitamin D levels 62 Digital Mammographic Imaging 62 cerebral infarction 62 pituitary adenomas 62 premalignant lesions 62 arterial thromboembolic events 62 Hurthle cell 62 ovarian pancreatic 62 Proteinuria 62 Uterine cancer 62 intima media thickness 62 proliferative diabetic retinopathy 62 narcolepsy cataplexy 62 varicella infection 62 axillary lymph nodes 62 chest radiographs 62 oropharyngeal squamous cell carcinoma 62 myopathy rhabdomyolysis 62 Prostate Specific Antigen 62 GBA mutations 62 cervicitis 62 undergone radical prostatectomy 62 serum IgE 62 urinary bladder cancer 62 Fasting blood glucose 62 uterine tumors 62 pheochromocytoma 62 obstructive coronary 62 serum BDNF 62 varicocele 62 highest tertile 62 recurrent miscarriage 62 oophorectomy 62 bioavailable testosterone 62 estrogen receptor negative 62 liver transaminases 62 serum folate concentrations 62 elevated creatinine 62 uterine cancers 62 genital herpes infections 62 PREZISTA r arm 62 Ischemic 62 subtrochanteric 62 transfusion syndrome 62 LUTS 62 FASLODEX 62 hyperplasia BPH 62 invasive candidiasis 62 homocysteine concentrations 62 tumor histology 62 serum parathyroid hormone 62 androgen ablation 62 haematologic 62 ejaculatory dysfunction 62 inhibin B 62 oral antidiabetic medication 62 recurrent glioblastoma multiforme 62 medullary thyroid cancer 62 Stomatitis 62 sonographically 62 severe periodontitis 62 Duodenal 62 preterm deliveries 62 ARCALYST ® 62 prostatic hyperplasia 61 carcinoid tumor 61 protein excretion 61 autoimmune thyroid 61 infliximab etanercept 61 lymphomas leukemias 61 colon tumors 61 LNG IUS 61 multivariable adjusted 61 severe exacerbations 61 curative resection 61 fructose intolerance 61 elevated triglyceride levels 61 cervical lymph nodes 61 glycated hemoglobin levels 61 Anaplastic 61 secondary amenorrhea 61 Serious Infections 61 hirsutism 61 perioperatively 61 papillary 61 baseline LDH 61 severe neutropenia 61 Folate deficiency 61 leukocyte counts 61 laparoscopically assisted 61 follicular lymphoma FL 61 microsatellite instability 61 postoperative infection 61 Pneumocystis carinii pneumonia 61 Prehypertension 61 Squamous cell 61 benign breast 61 colorectal polyps 61 Vitamin B# deficiency 61 Osteopenia 61 squamous histology 61 plasma homocysteine levels 61 spontaneous bacterial peritonitis 61 mesotheliomas 61 bacterial vaginosis BV 61 nonalcoholic steatohepatitis NASH 61 iPTH 61 thromboses 61 proctitis 61 thyroxine T4 61 Homocysteine levels 61 gestational diabetes mellitus GDM 61 serum homocysteine 61 colonic polyps 61 Precancerous 61 steroid dexamethasone 61 esophageal adenocarcinoma 61 bowel polyps 61 STRIDE PD 61 colorectal liver metastases 61 LHRH agonists 61 EpCAM expression 61 carotid plaques 61 ABCB1 61 bacterial prostatitis 61 hyperhomocysteinemia 61 diabetes mellitus DM 61 HPV subtypes 61 TNF blocker therapy 61 elevated triglycerides 61 nonsmall cell lung cancer 61 postmenopausal estrogen 61 grade gliomas 61 latent tuberculosis infection 61 urine albumin 61 PHPT 61 mmHg diastolic 61 β blockers 61 varices 61 Thalomid ® 61 antigen PSA 61 FOLFOX6 61 tamoxifen Nolvadex ® 61 hepatocellular carcinomas 61 Toxicities 61 sentinel nodes 61 generalized edema 61 hemoglobin A1c levels 61 precancerous cervical lesions 61 lymph node metastasis 61 Subarachnoid hemorrhage 61 liver metastasis 61 lactate dehydrogenase LDH 61 PCA3 scores 61 underactive thyroid gland 61 choriocarcinoma 61 anastomotic leak 61 vitamin D inadequacy 61 sCJD 61 thyroid stimulating hormone TSH 61 pathologic examination 61 dysmenorrhoea 61 hypercholesterolaemia 61 progressive dyspnea 61 urate levels 61 torsade de pointes 61 serum testosterone levels 61 anthracycline taxane 61 gestational hypertension 61 triiodothyronine 61 Prostate Specific Antigen PSA 61 arterial thickening 61 paricalcitol 61 postmenopausal hormones 61 minimally symptomatic 61 cTnI 61 Rectal cancer 61 ERalpha 61 leiomyoma 61 squamous cell carcinoma SCC 61 cranial irradiation 61 aminotransferase levels 61 apolipoprotein E4 61 pT2 61 plasma homocysteine 61 endometrial biopsy 61 leukoencephalopathy 61 ventricular tachyarrhythmia 61 lactate dehydrogenase 61 NP CRNs 61 Fatty Liver Disease 61 distant metastasis 61 fluvastatin 61 nonfasting triglyceride levels 61 pulmonary hypertension PH 61 BRCA1 BRCA2 61 poor metabolizers 61 locoregional recurrence 61 osteoid 61 familial pancreatic cancer 61 Myocardial infarction 61 Enlarged prostate 61 cytologic 61 lung metastasis 61 thromboembolic complications 61 gynecologic malignancy 61 T1DM 61 unresectable tumors 61 hematologic parameters 61 metastatic lung cancer 61 malignant neoplasms 61 BRCA mutation carriers 61 anovulation 61 abnormal mammograms 61 hypervascular tumors 61 FDG uptake 61 intestinal metaplasia 61 seminoma 61 aromatase inhibitors AIs 61 lymphadenopathy 61 biochemical relapse 61 hypercalcemia 61 benign nodules 61 enzyme elevations 61 benign prostatic hypertrophy 61 HbA 1c levels 61 nonproliferative 61 densest breasts 61 Insulin sensitivity 61 annualized relapse 61 pancreatic prostate 61 coronary stenosis 61 neuroendocrine cancers 61 lymph node metastases 61 neoadjuvant radiation 61 Helicobacter pylori infection 61 Pelvic Inflammatory Disease 61 intraepithelial neoplasia 61 biochemical recurrence 61 albumin excretion rate 61 cTnT levels 61 diabetic kidney 61 PIGF 61 irregular menstrual cycles 61 contralateral breast 61 perimenopausal women 61 octreotide LAR 61 invasive ductal breast cancer 61 hypovitaminosis D 61 vaginal lesions 61 BMPR2 61 Postmenopausal 61 SHBG levels 61 grade dysplasia 61 C Reactive Protein 61 systemic corticosteroid 61 ertapenem 61 invasive fungal infection 61 DFMO 61 Carcinomas 61 amenorrhoea 61 autoantibody positive 61 neurodevelopmental impairment 61 anal lesions 61 hyperparathyroidism 61 wound dehiscence 61 Prostate specific antigen 61 ovarian carcinoma 60 univariate analyzes 60 creatinine levels 60 systolic dysfunction 60 abnormal mammogram 60 nodular lesions 60 haloperidol Haldol 60 baseline serum creatinine 60 conjugated estrogen 60 chromosomal aberrations 60 BRCA deficient 60 thymoma 60 overt nephropathy 60 thromboembolism 60 neoadjuvant therapy 60 breast abscesses 60 malignant ovarian 60 GH deficiency 60 FluCAM arm 60 cirrhosis liver failure 60 mineral density BMD 60 Renal Cell Carcinoma RCC 60 Oral contraceptive 60 seropositive patients 60 Non Alcoholic Fatty 60 preoperative chemotherapy 60 bronchogenic carcinoma 60 deep venous thrombosis 60 urethritis 60 breast tenderness 60 underwent coronary angiography 60 postoperative delirium 60 helical CT 60 hematologic toxicity 60 MAGE A3 ASCI 60 hormone therapy HT 60 clomipramine 60 anastrazole 60 telomere lengths 60 Cutaneous T 60 intensive statin therapy 60 atherosclerotic progression 60 cholinergic tone 60 endocrine therapies 60 Hormonal therapy 60 depot medroxyprogesterone acetate 60 genital ulcer disease 60 hematuria 60 Ishak fibrosis score 60 median survivals 60 transaminases 60 carcinoid tumors 60 anti JCV antibodies 60 conventional antipsychotics 60 Thrombocytopenia 60 onset diabetes mellitus 60 Human papilloma virus 60 Bisphosphonate 60 transabdominal 60 cutaneous melanoma 60 receiving VELCADE 60 eosinophil count 60 serum calcium 60 hepatocellular carcinoma liver 60 neonatal morbidity 60 Hepatotoxicity 60 cervical vaginal 60 trastuzumab Herceptin ® 60 bullous 60 symptomatic BPH 60 microdeletions 60 proton MR spectroscopy 60 colorectal carcinomas 60 receiving XGEVA 60 TP# mutations 60 esophageal carcinoma 60 Uterine fibroids 60 serum triglycerides 60 TT genotype 60 alpha interferons 60 neuroblastoma tumors 60 infectious syphilis 60 repigmentation 60 HER2 positivity 60 postoperative infections 60 osteopenic 60 metastatic lesions 60 pulmonary dysfunction 60 Infusion Reactions Severe 60 Acute myeloid leukemia 60 RAS mutations 60 ovarian hormones 60 postoperative pulmonary 60 chlamydia infections 60 hepatic enzyme 60 underwent surgical resection 60 Hb A1C 60 HPA axis suppression 60 HBV infection 60 melanoma lesions 60 microscopic hematuria 60 pulmonary angiography 60 hyperalgesia 60 chlamydial 60 metaplasia 60 hyperphenylalaninemia HPA due 60 pathologic fracture 60 acarbose 60 brain lesions 60 chemoradiation therapy 60 vaginal hysterectomy 60 familial ALS 60 androgen deficiency 60 dalteparin 60 Renal Cell Carcinoma 60 INCB# [003] 60 primary ovarian insufficiency 60 acute gout flares 60 nephrolithiasis 60 extracolonic findings 60 corticosteroid dose 60 spirometric 60 myelogenous leukemia 60 isoprostane 60 CYT# potent vascular disrupting 60 metastatic neuroendocrine tumors 60 thrombotic complications 60 danazol 60 induce orthostatic hypotension 60 intravesical therapy 60 transaminase elevations 60 symptomatic intracranial 60 KRAS mutations 60 Advanced Melanoma 60 lowest tertile 60 breast carcinomas 60 gastrointestinal stromal tumors GISTs 60 CLA supplementation 60 anti androgen 60 nonmetastatic 60 ticlopidine 60 lipoprotein Lp 60 Nesiritide 60 urinary calcium 60 basal cell cancers 60 aspartate aminotransferase 60 malignant lesions 60 Hematologic 60 colon rectal 60 HNSCC 60 histologic subtypes 60 elevated uric acid 60 asymptomatic PAD 60 pyloric stenosis 60 endometrial 60 overexpress HER2 60 adrenal insufficiency 60 HeFH 60 Progestin 60 rheumatoid factor 60 carotid artery intima media 60 esophagogastroduodenoscopy 60 Response Evaluation Criteria 60 familial adenomatous polyposis 60 syncopal 60 Subgroup analyzes 60 Pemetrexed 60 impair fertility 60 Hyperkalemia 60 venous blood clots 60 fibrosis progression 60 Pegylated Interferon 60 cytopenias 60 postmenopausal hormone therapy 60 Nodules 60 mg BID dose 60 nodal metastases 60 ovarian malignancy 60 precancerous polyp 60 antidiabetic medication 60 Ovary removal 60 prostate ovarian 60 serum concentrations 60 mIU ml 60 dysplastic lesions 60 lumbar spine BMD 60 prostate carcinoma 60 AST ALT 60 plasma triglycerides 60 neurocognitive impairment 60 Hormone Refractory Prostate Cancer 60 recurrent metastatic 60 Chlamydia infection 60 Levels Linked 60 mcg kg REBETOL 60 Patients Receiving 60 pharyngeal cancer 60 Lp PLA 2 60 plasma folate 60 thrombocytopenic 60 detectable HCV RNA 60 Non Alcoholic Steatohepatitis 60 perfusion abnormalities 60 Breast Cancers 60 thromboembolisms 60 serum phosphorous 60 HBeAg 60 Androgen Deprivation Therapy 60 MULTAQ 60 Benign prostatic hyperplasia BPH 60 Breast Density 60 nonvaccine 60 hemodilution 60 nondiabetic patients 60 incidentalomas 60 inducible nitric oxide synthase 60 bezafibrate 60 MCyR 60 carotid plaque 60 cisplatin resistant 60 scintigraphic 60 KRAS mutant tumors 60 histopathologic examination 60 postoperative AF 60 Xelox 60 SCr 60 operable breast cancer 60 dysuria 60 rectal gonorrhea 60 ovulatory cycles 60 nonpregnant women 60 poorer prognosis 60 prostate cancer metastases 60 GSTT1 60 comorbid illnesses 60 antiandrogens 60 Leydig cell 60 CrCl 60 Renal dysfunction 60 Ki# 60 anemia neutropenia 60 creatinine ratio 60 leukemia ALL 60 carotid IMT 60 morphometric vertebral fractures 60 radioiodine therapy 60 dose Iluvien 60 detrusor overactivity 60 receiving Vectibix monotherapy 60 pancreatic adenocarcinoma 60 pyelonephritis 60 BRAF mutations 60 oral squamous cell 60 androgen suppression therapy 60 bilirubin levels 60 sustained virological response 60 Helicobacter pylori eradication 60 digital rectal examination 60 pentoxifylline 60 superficial bladder cancer 60 albuminuria 60 colorectal cancer incidence 60 symptomatic fibroids 60 KRAS mutations occur 60 PCa 60 Breast Cancer Recurrence 60 Clusterin 60 intracranial hemorrhage ICH 60 IL 1ß 60 Darapladib 60 serum potassium levels 60 underwent resection 60 atypical fractures 60 hematologic abnormalities 60 femoral neck BMD 60 renal toxicity 60 Viral load 60 Endometrial Cancer 60 neoplasm 60 parathyroid carcinoma 60 Unstable Angina 60 polycystic ovarian syndrome PCOS 60 BRCA mutation 60 intraoperative complications 60 XIENCE V PROMUS Stent 60 precocious puberty 60 myocardial fibrosis 60 estrogen hormone therapy 60 hormone receptor status 60 cervical dysplasia 60 euthyroid 60 metastatic prostate 60 coronary blockages 60 prostate cancer PCa 60 LV dysfunction 60 nephrotoxic drugs 60 #F FDG PET 60 calculi 60 metastatic malignant melanoma 60 troponins 60 D dimer 60 Natalizumab 60 psychiatric comorbidities 60 sonographic findings 60 oral pharyngeal 59 Prostate Cancer Risk 59 histopathologic findings 59 efalizumab 59 Catheter Associated 59 taxane chemotherapy 59 proximal colon 59 micrometastases 59 endoxifen 59 Cytogenetic 59 urinary albumin 59 lupus anticoagulant 59 abnormal genital 59 thyroid cancers 59 Radical prostatectomy 59 anal HPV 59 beta blocker therapy 59 left ventricular hypertrophy 59 myocardial infarctions MIs 59 Antitumor Activity 59 CCyR 59 Relapsing remitting MS 59 nicardipine 59 Improves Outcomes 59 carcinoembryonic antigen 59 bladder tumors 59 mycophenolate mofetil 59 umol L 59 hyperprolactinemia 59 pre cancerous polyps 59 Breslow thickness 59 ischemic colitis 59 mammographic breast density 59 subclinical disease 59 triacylglycerol concentrations 59 ARB telmisartan